Amplify Weight Loss Drug & Treatment ETF
(THNR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | THNR | ||||
| Company | Amplify Weight Loss Drug & Treatment ETF | ||||
| Price Information | |||||
| Exchange | NYSE Arca | ||||
| Open | 26.05 | ||||
| High | 26.05 | ||||
| Low | 26.05 | ||||
| Latest | 26.05 | ||||
| Change | +0.01 | ||||
| % Change | +0.05% | ||||
| Volume | 212 | ||||
| 20-Day Average Volume | 5,456 | ||||
| Previous Close | 26.04 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 26.11 | ||||
| 20-Day Raw Stochastic | 35.81% | ||||
| 20-Day Relative Strength | 52.24 | ||||
| Weighted Alpha | +18.58 | ||||
| Today's Opinion | 72% Buy | ||||
| Previous Opinion | 72% Buy | ||||
| Last Month's Opinion | 100% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.30% since 02/04/26 | ||||
| Low | 25.36 on 02/05/26 | ||||
| High | 26.18 on 02/09/26 | ||||
| 1-Month | |||||
| %Chg | -0.22% since 01/09/26 | ||||
| Low | 25.36 on 02/05/26 | ||||
| High | 27.28 on 01/20/26 | ||||
| 3-Month | |||||
| %Chg | +6.49% since 11/11/25 | ||||
| Low | 24.68 on 12/09/25 | ||||
| High | 27.28 on 01/20/26 | ||||
| 6-Month | |||||
| %Chg | +18.40% since 08/11/25 | ||||
| Low | 21.96 on 08/12/25 | ||||
| High | 27.28 on 01/20/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 3,905 | ||||
| Shares Outstanding, K | 150 | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | 0 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | 0.61 | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | 0.220 on 12/30/24 | ||||
| Next Ex-Dividends Date | 12/30/24 | ||||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | ||||